- Investing Ideas
- /
- U.S. Buy the Dip
U.S. Buy the Dip
UPDATED Apr 22, 2024
Companies which may present a buying opportunity after a dip in share price.
652 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AXSM | US$71.10 | 3.3% | -0.2% | US$3.4b | US$121.13 | PS12.4x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.98 | -7.4% | -35.1% | US$220.6m | US$26.06 | PS4.6x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.19 | 2.7% | 70.3% | US$214.0m | US$8.50 | PS2.7x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.58 | -4.0% | -18.1% | US$191.3m | US$19.00 | PS7x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$14.26 | 1.9% | -36.3% | US$2.2b | US$29.75 | PE173.9x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$146.07 | -0.4% | -27.7% | US$18.4b | US$220.00 | PS10.1x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
FTCI | US$0.39 | -3.1% | -84.8% | US$49.3m | n/a | PB0.8x | E63.1% | n/a | Capital Goods | ||
SONM | US$0.48 | -4.2% | -57.4% | US$21.0m | US$2.00 | PB0.9x | E139.9% | n/a | Tech | ||
ARDX | US$6.51 | -3.0% | 41.2% | US$1.5b | US$13.50 | PS12.2x | E59.6% | n/a | Pharmaceuticals & Biotech | ||
FOLD | US$10.82 | 2.5% | -6.3% | US$3.2b | US$18.78 | PS8x | E55.2% | n/a | Pharmaceuticals & Biotech | ||
BRDG | US$6.62 | -2.9% | -33.5% | US$808.7m | US$10.00 | PS1x | E88.9% | 10.0% | Diversified Financials | ||
ACAD | US$16.74 | -2.0% | -16.8% | US$2.8b | US$29.09 | PS3.8x | E40.9% | n/a | Pharmaceuticals & Biotech | ||
SMWB | US$7.91 | 6.2% | 38.5% | US$594.3m | US$10.83 | PS2.9x | E104.3% | n/a | Software | ||
WULF | US$2.70 | 44.0% | 94.2% | US$779.8m | US$3.62 | PS11.8x | E132.9% | n/a | Software | ||
MLCO | US$6.20 | -10.0% | -53.1% | US$2.7b | US$10.91 | PE-8.3x | E54.9% | 0% | Consumer Services | ||
AZ | US$0.45 | 7.2% | -60.1% | US$20.6m | US$18.00 | PS2x | E75.4% | n/a | Capital Goods | ||
OPTN | US$0.97 | -11.0% | -45.2% | US$116.0m | US$3.75 | PS1.5x | E61.6% | n/a | Pharmaceuticals & Biotech | ||
HHH | US$64.10 | 7.3% | -14.5% | US$3.1b | US$88.25 | PS3.1x | E107.2% | n/a | Real Estate Management and Development | ||
MVST | US$0.46 | -14.0% | -52.6% | US$158.5m | US$4.50 | PB0.3x | E44.4% | n/a | Capital Goods | ||
ZS | US$176.90 | 1.5% | 91.6% | US$25.6b | US$258.52 | PS14x | E41.1% | n/a | Software | ||
BIGC | US$5.76 | -2.2% | -25.6% | US$442.3m | US$9.68 | PS1.4x | E67.9% | n/a | Software | ||
AJX | US$3.66 | 0.5% | -43.9% | US$132.4m | US$6.00 | PB0.5x | E146.1% | 10.9% | Diversified Financials | ||
OWLT | US$4.02 | 20.0% | -20.7% | US$36.8m | US$15.00 | PE-1x | E73.7% | n/a | Healthcare | ||
SACH | US$3.19 | -1.5% | -7.0% | US$149.0m | US$4.42 | PE12.5x | E30.2% | 13.8% | Diversified Financials |